Cite
HARVARD Citation
Ogawa, E. et al. (2015). Non-Invasive Fibrosis Assessment Predicts Sustained Virological Response to Telaprevir with Pegylated Interferon and Ribavirin for Chronic Hepatitis C. Antiviral therapy. 20 (2), pp. 185-192. [Online].